KRAS G12C LUNG CANCER

Clinical trials for KRAS G12C LUNG CANCER explained in plain language.

Never miss a new study

Get alerted when new KRAS G12C LUNG CANCER trials appear

Sign up with your email to follow new studies for KRAS G12C LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

New hope for Tough-to-Treat lung cancer: trial tests targeted combo

Disease control Not yet recruiting

This study is testing a new combination of drugs given before and after surgery for patients with a specific genetic type of lung cancer (called KRAS G12C). The goal is to see if this approach can shrink or eliminate the cancer in the tumor before it's removed and prevent it from…

Matched conditions: KRAS G12C LUNG CANCER

Phase: PHASE2 • Sponsor: Guangdong Provincial People's Hospital • Aim: Disease control

Last updated Mar 24, 2026 12:03 UTC

KRAS G12C LUNG CANCER

Get alerted when new KRAS G12C LUNG CANCER trials appear

New hope for Tough-to-Treat lung cancer: trial tests targeted combo